Interleukin-21 in Immune and Allergic Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 313-319

Bentham Science Publishers

Access to resources Recommend Favorite

IL-5 Inhibition as a Therapy for Allergic Disease

By Garlisi C.G.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 81-85

Academic Press

Access to resources Recommend Favorite

Interleukin-5, Eosinophilic Diseases and Therapeutic Intervention

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 4, 2003-12 ,pp. : 319-328

Bentham Science Publishers

Access to resources Recommend Favorite

The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

No involvement of interleukin-5 or eosinophils in experimental allergic rhinitis in guinea pigs

By Yamasaki M.   Mizutani N.   Sasaki K.   Nabe T.   Kohno S.  

European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. : 159-169

Elsevier

Access to resources Recommend Favorite